Valuation: Guilin Sanjin Pharmaceutical Co., Ltd.

Market Cap 8B 1.2B 1.08B 992M 898M 1.68B 114B 1.71B 11.84B 4.72B 59.85B 4.51B 4.41B 190B P/E 2024
17x
P/E 2025 19.1x
Enterprise Value 6.8B 1.02B 913M 843M 762M 1.43B 97.1B 1.45B 10.05B 4.01B 50.82B 3.83B 3.75B 161B EV / Sales 2024
3.55x
EV / Sales 2025 3.46x
Free-Float
22.45%
Yield 2024
3.98%
Yield 2025 3.55%
1 day+10.02%
1 week+13.22%
Current month+11.46%
1 month+12.84%
3 months+3.03%
6 months-4.29%
Current year-3.40%
1 week 12.05
Extreme 12.05
13.62
1 month 11.82
Extreme 11.82
13.62
Current year 11.82
Extreme 11.82
14.95
1 year 11.82
Extreme 11.82
15.75
3 years 11.28
Extreme 11.28
18.35
5 years 10.59
Extreme 10.59
21.67
10 years 10.59
Extreme 10.59
21.67
Manager TitleAgeSince
Chief Executive Officer 50 -
Director of Finance/CFO 49 27/12/2025
Corporate Officer/Principal 56 26/12/2022
Director TitleAgeSince
Chairman 50 14/01/2022
Director/Board Member 46 26/12/2019
Director/Board Member 53 -
Date Insider Type Main position Quantity % Market Cap. Importance
4/29/24 A Buy

Chairman

148,300 0.0268%
9/29/20 A Sell

Chairperson

89,100 0.0165%
Change 5-day change 1-year change 3-year change Capi.($)
+10.02%+13.22%-10.10%-10.10% 1.2B
+6.63%+5.13%+68.86%+145.20% 1,224B
+1.53%+2.84%+47.48%+89.01% 662B
+1.68%+1.96%+29.16%+109.31% 514B
+0.47%+3.45%+54.53%+67.59% 388B
+3.83%-0.62%+69.01%+42.32% 361B
+0.83%+4.14%+34.81%+57.51% 302B
+2.96%+4.66%+6.98%+31.36% 271B
+1.97%+3.01%+57.91%+76.14% 249B
+4.03%+5.36%+39.76%+116.14% 205B
Average +2.97%+3.58%+39.84%+72.45% 417.8B
Weighted average by Cap. +2.15%+3.04%+50.69%+96.46%

Financials

2024 2025
Net sales 2.19B 329M 295M 272M 246M 460M 31.35B 468M 3.25B 1.29B 16.41B 1.24B 1.21B 51.97B 2.05B 307M 275M 254M 230M 429M 29.23B 436M 3.03B 1.21B 15.3B 1.15B 1.13B 48.45B
Net income 522M 78.26M 70.09M 64.67M 58.52M 109M 7.45B 111M 772M 308M 3.9B 294M 287M 12.35B 433M 64.99M 58.21M 53.71M 48.6M 90.88M 6.19B 92.35M 641M 256M 3.24B 244M 239M 10.26B
Net Debt -1.08B -162M -145M -134M -121M -227M -15.46B -231M -1.6B -639M -8.09B -609M -596M -25.63B -1.21B -181M -162M -150M -135M -253M -17.25B -257M -1.79B -713M -9.03B -680M -666M -28.6B
Projected Income Statement - Annual - Guilin Sanjin Pharmaceutical Co., Ltd.
Logo Guilin Sanjin Pharmaceutical Co., Ltd.
Guilin Sanjin Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of Chinese patent medicines. The Company mainly operates in the two major areas of oral and throat health and urinary health, including the prevention, self-treatment and rehabilitation of common household diseases such as cardiovascular and cerebrovascular, nervous system, respiratory system and digestive system. The Company's main products include Sanjin Tablets, Guilin Xiguashuang, Xiguashuang Throat Tablets, Xiguashuang Qingyan Lozenges, Naomaitai Capsules, Xuanyunning Tablets/Granules, Gejie Dingchuan Capsules, Yuye Jiedu Granules.
Employees
2,556
Date Price Change Volume
29/10/26 CN¥13.62 +10.02% 23,125,663
28/10/26 CN¥12.38 +2.57% 3,485,190
27/10/26 CN¥12.07 -1.47% 1,133,400
26/10/26 CN¥12.25 +1.16% 1,361,502
23/10/26 CN¥12.11 +0.67% 1,694,000

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Guilin Sanjin Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002275 Stock